 Edward Chuong
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endogenous Retroviruses | 8 | 2024 | 37 | 4.060 |
Why?
| | DNA Transposable Elements | 10 | 2026 | 124 | 3.690 |
Why?
| | Evolution, Molecular | 7 | 2024 | 494 | 1.810 |
Why?
| | Regulatory Sequences, Nucleic Acid | 4 | 2023 | 92 | 1.380 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2025 | 1450 | 1.190 |
Why?
| | Enhancer Elements, Genetic | 6 | 2024 | 191 | 1.070 |
Why?
| | Gene Regulatory Networks | 4 | 2024 | 318 | 1.010 |
Why?
| | Interferon-gamma | 2 | 2023 | 784 | 0.970 |
Why?
| | Placenta | 7 | 2018 | 787 | 0.890 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 35 | 0.850 |
Why?
| | Promoter Regions, Genetic | 3 | 2024 | 1247 | 0.830 |
Why?
| | Exons | 1 | 2024 | 364 | 0.780 |
Why?
| | Gene Expression Regulation | 4 | 2022 | 2601 | 0.740 |
Why?
| | Alternative Splicing | 1 | 2024 | 248 | 0.730 |
Why?
| | Retroelements | 1 | 2022 | 50 | 0.720 |
Why?
| | Signal Transduction | 5 | 2024 | 5224 | 0.710 |
Why?
| | Gene Editing | 1 | 2023 | 89 | 0.700 |
Why?
| | CRISPR-Cas Systems | 1 | 2023 | 166 | 0.670 |
Why?
| | Immunity, Innate | 3 | 2024 | 835 | 0.560 |
Why?
| | Animals | 31 | 2026 | 38102 | 0.550 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2018 | 72 | 0.540 |
Why?
| | Ovarian Neoplasms | 4 | 2025 | 596 | 0.540 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 4 | 2025 | 134 | 0.470 |
Why?
| | Colorectal Neoplasms | 1 | 2024 | 868 | 0.470 |
Why?
| | Genome | 6 | 2026 | 305 | 0.470 |
Why?
| | Histone-Lysine N-Methyltransferase | 3 | 2024 | 141 | 0.450 |
Why?
| | Mammals | 3 | 2023 | 286 | 0.410 |
Why?
| | Dosage Compensation, Genetic | 1 | 2013 | 12 | 0.400 |
Why?
| | Ruminants | 2 | 2024 | 7 | 0.400 |
Why?
| | X Chromosome | 1 | 2013 | 66 | 0.400 |
Why?
| | Cell Line, Tumor | 7 | 2025 | 3551 | 0.390 |
Why?
| | Protein Isoforms | 2 | 2024 | 399 | 0.380 |
Why?
| | Drosophila | 1 | 2013 | 166 | 0.360 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1998 | 0.350 |
Why?
| | Drosophila Proteins | 1 | 2013 | 214 | 0.340 |
Why?
| | Pregnancy Proteins | 2 | 2011 | 36 | 0.330 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 693 | 0.300 |
Why?
| | Genomics | 3 | 2026 | 830 | 0.290 |
Why?
| | Stem Cells | 2 | 2013 | 630 | 0.290 |
Why?
| | Maternal-Fetal Exchange | 1 | 2010 | 170 | 0.280 |
Why?
| | Whole Genome Sequencing | 2 | 2026 | 178 | 0.270 |
Why?
| | Chromatin | 3 | 2024 | 553 | 0.250 |
Why?
| | Placentation | 3 | 2017 | 52 | 0.250 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 883 | 0.250 |
Why?
| | Transcription Factors | 2 | 2016 | 1736 | 0.240 |
Why?
| | Genome, Insect | 1 | 2026 | 28 | 0.230 |
Why?
| | Bees | 1 | 2026 | 37 | 0.230 |
Why?
| | Adaptation, Physiological | 2 | 2025 | 560 | 0.230 |
Why?
| | HEK293 Cells | 2 | 2025 | 741 | 0.220 |
Why?
| | Phthalazines | 1 | 2025 | 63 | 0.220 |
Why?
| | Polymorphism, Genetic | 2 | 2026 | 615 | 0.220 |
Why?
| | Boidae | 1 | 2025 | 31 | 0.220 |
Why?
| | Interferon-beta | 1 | 2025 | 92 | 0.220 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2024 | 26 | 0.210 |
Why?
| | RNA Stability | 1 | 2025 | 107 | 0.210 |
Why?
| | Transcription, Genetic | 3 | 2024 | 1454 | 0.200 |
Why?
| | Rhabdomyosarcoma | 1 | 2024 | 65 | 0.200 |
Why?
| | beta Catenin | 1 | 2025 | 254 | 0.200 |
Why?
| | Pregnancy | 7 | 2018 | 7216 | 0.200 |
Why?
| | Interferons | 1 | 2024 | 186 | 0.190 |
Why?
| | Humans | 22 | 2025 | 145783 | 0.190 |
Why?
| | Piperazines | 1 | 2025 | 375 | 0.190 |
Why?
| | Mice | 10 | 2025 | 18356 | 0.190 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2024 | 212 | 0.180 |
Why?
| | Carcinogenesis | 1 | 2024 | 228 | 0.180 |
Why?
| | Gene Knockout Techniques | 1 | 2023 | 119 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 910 | 0.180 |
Why?
| | Binding Sites | 2 | 2023 | 1311 | 0.180 |
Why?
| | Gene Targeting | 1 | 2021 | 81 | 0.170 |
Why?
| | Biological Evolution | 2 | 2023 | 468 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 86 | 0.170 |
Why?
| | Telomere | 1 | 2024 | 287 | 0.170 |
Why?
| | Software | 1 | 2026 | 680 | 0.160 |
Why?
| | RNA, Untranslated | 1 | 2021 | 121 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2021 | 224 | 0.160 |
Why?
| | Cattle | 1 | 2022 | 946 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2024 | 740 | 0.150 |
Why?
| | Cell Line | 2 | 2023 | 2823 | 0.140 |
Why?
| | Haplorhini | 1 | 2018 | 52 | 0.140 |
Why?
| | RNA, Long Noncoding | 2 | 2021 | 172 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 923 | 0.140 |
Why?
| | Eutheria | 1 | 2017 | 3 | 0.130 |
Why?
| | Primates | 1 | 2018 | 133 | 0.130 |
Why?
| | Selection, Genetic | 3 | 2024 | 263 | 0.120 |
Why?
| | Endonucleases | 1 | 2016 | 34 | 0.120 |
Why?
| | Xenopus | 2 | 2013 | 87 | 0.120 |
Why?
| | RNA, Fungal | 1 | 2016 | 67 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 139 | 0.120 |
Why?
| | Lactation | 1 | 2017 | 193 | 0.120 |
Why?
| | Genome, Human | 2 | 2016 | 422 | 0.120 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2016 | 78 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 1969 | 0.120 |
Why?
| | Molecular Sequence Annotation | 2 | 2026 | 106 | 0.110 |
Why?
| | Endoderm | 2 | 2011 | 21 | 0.110 |
Why?
| | Inflammasomes | 1 | 2016 | 144 | 0.110 |
Why?
| | Female | 12 | 2026 | 79045 | 0.110 |
Why?
| | Rats | 3 | 2013 | 5585 | 0.100 |
Why?
| | Trophoblasts | 2 | 2013 | 218 | 0.100 |
Why?
| | Embryonic Stem Cells | 2 | 2011 | 124 | 0.100 |
Why?
| | Terminal Repeat Sequences | 1 | 2013 | 17 | 0.100 |
Why?
| | Forkhead Transcription Factors | 2 | 2011 | 209 | 0.100 |
Why?
| | Phylogeny | 2 | 2024 | 917 | 0.100 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 188 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2013 | 534 | 0.090 |
Why?
| | Acetylation | 1 | 2013 | 259 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 574 | 0.090 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2011 | 2 | 0.090 |
Why?
| | Species Specificity | 1 | 2013 | 546 | 0.090 |
Why?
| | Nodal Protein | 1 | 2011 | 3 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2025 | 936 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2219 | 0.080 |
Why?
| | Histones | 2 | 2013 | 666 | 0.080 |
Why?
| | Cathepsins | 1 | 2010 | 24 | 0.080 |
Why?
| | Prolactin | 1 | 2010 | 87 | 0.080 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 64 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2131 | 0.070 |
Why?
| | Neoplasms | 1 | 2024 | 2913 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1482 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2010 | 2883 | 0.070 |
Why?
| | Rodentia | 1 | 2008 | 61 | 0.070 |
Why?
| | Spermatogenesis | 1 | 2008 | 91 | 0.070 |
Why?
| | Testis | 1 | 2008 | 162 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1300 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 835 | 0.060 |
Why?
| | Tristetraprolin | 1 | 2025 | 8 | 0.060 |
Why?
| | Gammaherpesvirinae | 1 | 2025 | 45 | 0.050 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 17 | 0.050 |
Why?
| | Drug Synergism | 1 | 2025 | 354 | 0.050 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 43 | 0.050 |
Why?
| | Horses | 1 | 2026 | 226 | 0.050 |
Why?
| | Diploidy | 1 | 2024 | 17 | 0.050 |
Why?
| | Genetics, Population | 1 | 2026 | 217 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 102 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1777 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2025 | 212 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 19 | 0.050 |
Why?
| | Protein Binding | 3 | 2016 | 2240 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2023 | 79 | 0.050 |
Why?
| | Snake Venoms | 1 | 2022 | 20 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 1023 | 0.040 |
Why?
| | Virus Replication | 1 | 2025 | 521 | 0.040 |
Why?
| | Crotalus | 1 | 2022 | 24 | 0.040 |
Why?
| | Mutation | 1 | 2013 | 4090 | 0.040 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 14 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 447 | 0.040 |
Why?
| | MicroRNAs | 2 | 2021 | 686 | 0.040 |
Why?
| | Computational Biology | 1 | 2026 | 669 | 0.040 |
Why?
| | Genetic Variation | 1 | 2026 | 977 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 638 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 381 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2865 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1478 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2805 | 0.030 |
Why?
| | Milk | 1 | 2017 | 119 | 0.030 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 8 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2017 | 128 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2024 | 2514 | 0.030 |
Why?
| | Male | 4 | 2026 | 73011 | 0.030 |
Why?
| | Mediator Complex | 1 | 2016 | 61 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2014 | 2050 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 163 | 0.030 |
Why?
| | Polyploidy | 1 | 2014 | 14 | 0.030 |
Why?
| | Stochastic Processes | 1 | 2014 | 65 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4568 | 0.020 |
Why?
| | Base Sequence | 1 | 2016 | 2171 | 0.020 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 108 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2014 | 451 | 0.020 |
Why?
| | Gene Deletion | 1 | 2014 | 392 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2016 | 414 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 157 | 0.020 |
Why?
| | Physiology, Comparative | 1 | 2011 | 3 | 0.020 |
Why?
| | Fetal Proteins | 1 | 2011 | 15 | 0.020 |
Why?
| | Left-Right Determination Factors | 1 | 2011 | 1 | 0.020 |
Why?
| | Gastrulation | 1 | 2011 | 9 | 0.020 |
Why?
| | Smad Proteins | 1 | 2011 | 42 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 219 | 0.020 |
Why?
| | Immunomodulation | 1 | 2011 | 99 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 242 | 0.020 |
Why?
| | Organ Specificity | 1 | 2011 | 309 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2011 | 189 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 751 | 0.020 |
Why?
| | Lysine | 1 | 2011 | 305 | 0.020 |
Why?
| | Peromyscus | 1 | 2008 | 5 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2008 | 43 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 362 | 0.020 |
Why?
| | Biomedical Research | 1 | 2011 | 719 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3418 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 7134 | 0.010 |
Why?
|
|
Chuong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|